newsfilter
← Latest News
GlobeNewswire·

OKYO Pharma Receives $1.4 Million in Non-Dilutive Funding

LONDON and NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ:OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP),